Carlos G. Grijalva, MD, MPH
Assistant Professor of Preventive Medicine
Vanderbilt University School of Medicine
Nashville, Tennessee


Carlos G. Grijalva, MD, MPH, is Assistant Professor of Preventive Medicine at Vanderbilt University and Co-Director of the Vanderbilt's Developing Evidence to Inform Decisions about Effectiveness (DEcIDE) research site. Dr. Grijalva was born in Peru and received his MD from Universidad Nacional San Luis Gonzaga, Ica, Peru. He has worked as primary physician in the Andean community of Oyon, in the Peruvian highlands. Dr. Grijalva completed a Specialization in Statistics and Research at Universidad Peruana Cayetano Heredia and worked for the General Directorate of Epidemiology-Peruvian Ministry of Health.

In 2004, Dr. Grijalva moved to the United States and received a short training in Tropical Medicine and Public Health at the Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland. After this, he joined the Department of Preventive Medicine at Vanderbilt University, where he earned his Master in Public Health degree in 2006. His current research is focused on vaccine preventable respiratory diseases, especially influenza and pneumococcal infections and the evaluation of the impact of vaccination programs. Dr. Grijalva has worked extensively estimating the incidence of influenza infections and quantifying the impact of preventative interventions, such as a countywide school-based influenza vaccination program in Tennessee, and the national implementation of routine vaccination with a seven-valent pneumococcal conjugate vaccine in the United States.